These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

128 related items for PubMed ID: 21393091

  • 1. The efficacy of bromides, stiripentol and levetiracetam in two patients with malignant migrating partial seizures in infancy.
    Djuric M, Kravljanac R, Kovacevic G, Martic J.
    Epileptic Disord; 2011 Mar; 13(1):22-6. PubMed ID: 21393091
    [Abstract] [Full Text] [Related]

  • 2. Levetiracetam in a neonate with malignant migrating partial seizures.
    Hmaimess G, Kadhim H, Nassogne MC, Bonnier C, van Rijckevorsel K.
    Pediatr Neurol; 2006 Jan; 34(1):55-9. PubMed ID: 16376281
    [Abstract] [Full Text] [Related]

  • 3. Malignant migrating partial seizures of infancy controlled by stiripentol and clonazepam.
    Merdariu D, Delanoë C, Mahfoufi N, Bellavoine V, Auvin S.
    Brain Dev; 2013 Feb; 35(2):177-80. PubMed ID: 22521903
    [Abstract] [Full Text] [Related]

  • 4. Potassium bromide for treatment of malignant migrating partial seizures in infancy.
    Ünver O, Incecik F, Dündar H, Kömür M, Ünver A, Okuyaz Ç.
    Pediatr Neurol; 2013 Nov; 49(5):355-7. PubMed ID: 23968569
    [Abstract] [Full Text] [Related]

  • 5. Adjunctive levetiracetam in infants and young children with refractory partial-onset seizures.
    Piña-Garza JE, Nordli DR, Rating D, Yang H, Schiemann-Delgado J, Duncan B, Levetiracetam N01009 Study Group.
    Epilepsia; 2009 May; 50(5):1141-9. PubMed ID: 19243423
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Onset of action of levetiracetam: a RCT trial using therapeutic intensive seizure analysis (TISA).
    Stefan H, Wang-Tilz Y, Pauli E, Dennhöfer S, Genow A, Kerling F, Lorber B, Fraunberger B, Halboni P, Koebnick C, Gefeller O, Tilz C.
    Epilepsia; 2006 Mar; 47(3):516-22. PubMed ID: 16529615
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Efficacy and safety of levetiracetam in the treatment of Panayiotopoulos syndrome.
    García C, Rubio G.
    Epilepsy Res; 2009 Aug; 85(2-3):318-20. PubMed ID: 19423296
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Add-on levetiracetam in children and adolescents with refractory epilepsy: results of an open-label multi-centre study.
    Callenbach PM, Arts WF, ten Houten R, Augustijn P, Gunning WB, Peeters EA, Weber AM, Stroink H, Geerts Y, Geerts AT, Brouwer OF.
    Eur J Paediatr Neurol; 2008 Jul; 12(4):321-7. PubMed ID: 17950011
    [Abstract] [Full Text] [Related]

  • 16. Efficacy and tolerability of the ketogenic diet in Dravet syndrome - Comparison with various standard antiepileptic drug regimen.
    Dressler A, Trimmel-Schwahofer P, Reithofer E, Mühlebner A, Gröppel G, Reiter-Fink E, Benninger F, Grassl R, Feucht M.
    Epilepsy Res; 2015 Jan; 109():81-9. PubMed ID: 25524846
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Efficacy of levetiracetam in partial seizures.
    Devinsky O, Elger C.
    Epileptic Disord; 2003 May; 5 Suppl 1():S27-31. PubMed ID: 12915338
    [Abstract] [Full Text] [Related]

  • 20. Catatonia induced by levetiracetam.
    Chouinard MJ, Nguyen DK, Clément JF, Bruneau MA.
    Epilepsy Behav; 2006 Feb; 8(1):303-7. PubMed ID: 16249124
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.